OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing cell-based cancer immunotherapy through stem cell engineering
Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 592-610
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67

Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Yan-Ruide Li, Ying Fang, Zibai Lyu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 64

A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20

Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19

Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1849-1874
Open Access | Times Cited: 18

Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
Agnete Kirkeby, Heather Main, Melissa Carpenter
Cell stem cell (2025) Vol. 32, Iss. 1, pp. 10-37
Closed Access | Times Cited: 10

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Shaoqiang Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3

Boosting CAR-T cell therapy through vaccine synergy
Yan-Ruide Li, Zibai Lyu, Xinyuan Shen, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 2

The future of affordable cancer immunotherapy
Niels Schaft, Jan Dörrie, Gerold Schuler, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 39

Frontiers in CAR-T cell therapy for autoimmune diseases
Yan-Ruide Li, Zibai Lyu, Yuning Chen, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 839-857
Open Access | Times Cited: 13

Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine
Lingxi Wei, Wenqi Yan, Wahid Shah, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35836-e35836
Open Access | Times Cited: 8

Advanced Nano Delivery System for Stem Cell Therapy for Alzheimer's Disease
Yilong Pan, Long Li, Ning Cao, et al.
Biomaterials (2024) Vol. 314, pp. 122852-122852
Closed Access | Times Cited: 7

Universal CAR 2.0 to overcome current limitations in CAR therapy
Lara Sophie Schlegel, Coralie Werbrouck, Michael Boettcher, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Yun Chang, Ming‐Yang Chang, Xiaoping Bao, et al.
Bioactive Materials (2024) Vol. 42, pp. 379-403
Open Access | Times Cited: 5

Tumour-associated macrophages: versatile players in the tumour microenvironment
Zoey Zeyuan Ji, Max Kam‐Kwan Chan, Alex Siu Wing Chan, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11

iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
Jiepu Zong, Yan-Ruide Li
Bioengineering (2025) Vol. 12, Iss. 1, pp. 60-60
Open Access

Helper ILCs in the human hematopoietic system
Xiaoyu Su, Zhaoqun Deng, Yu Lan, et al.
Trends in Immunology (2025)
Closed Access

Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
Yan-Ruide Li, Christopher Ochoa, Yichen Zhu, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107952-107952
Open Access | Times Cited: 10

CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy
Mohadeseh Mohammad Taheri, Fatemeh Javan, Mohadeseh Poudineh, et al.
Clinical Reviews in Allergy & Immunology (2024) Vol. 66, Iss. 3, pp. 328-362
Closed Access | Times Cited: 3

Advancements in CRISPR screens for the development of cancer immunotherapy strategies
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100733-100733
Open Access | Times Cited: 9

Engineered stem cells by emerging biomedical stratagems
Jinglin Wang, Xiaoxuan Zhang, Hanxu Chen, et al.
Science Bulletin (2023) Vol. 69, Iss. 2, pp. 248-279
Open Access | Times Cited: 8

Enhanced Cellular Uptake through Nanotopography‐Induced Macropinocytosis
Morteza Aramesh, Di Yu, Magnus Essand, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 28
Open Access | Times Cited: 2

Artificial Polymerizations in Living Organisms for Biomedical Applications
Yun Chen, Brynne Shu Ni Tan, Yu Cheng, et al.
Angewandte Chemie International Edition (2024)
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top